SPONSOR
Zhejiang Cancer Hospital
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 3
Conditions studied: Gastric CancerNasopharyngeal CarcinomaSmall Cell Lung Cancer Limited StageCardiotoxicity Induced by Drug Therapy for Breast CancerTumorStrokeIBI363 + ChemotherapyBrachytherapyUterine Cervical NeoplasmsUterine Neoplasms
Zhejiang Cancer Hospital is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Gastric Cancer, Nasopharyngeal Carcinoma, Small Cell Lung Cancer Limited Stage, Cardiotoxicity Induced by Drug Therapy for Breast Cancer.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhejiang Cancer Hospital
How many clinical trials has Zhejiang Cancer Hospital sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Zhejiang Cancer Hospital, of which 10 are actively recruiting participants. These trials cover conditions including Gastric Cancer, Nasopharyngeal Carcinoma, Small Cell Lung Cancer Limited Stage. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhejiang Cancer Hospital research focus on?
Zhejiang Cancer Hospital clinical trials span Gastric Cancer, Nasopharyngeal Carcinoma, Small Cell Lung Cancer Limited Stage, Cardiotoxicity Induced by Drug Therapy for Breast Cancer, Tumor, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhejiang Cancer Hospital clinical trial?
To participate in a Zhejiang Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhejiang Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Zhejiang Cancer Hospital
NCT07067983
Recruiting
Clinical Evaluation of GRAPE Model for Gastric Cancer Screening
Gastric Cancer
NCT06055816 Phase 2
Recruiting
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
NCT05651802
Recruiting
PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients
Small Cell Lung Cancer Limited Stage
NCT06214195 Phase 3
Recruiting
The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
NCT06711432
Recruiting
Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）
Tumor
NCT07325630 Phase 2
Recruiting
Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
IBI363 + Chemotherapy
NCT05813626 Phase 2
Recruiting
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
NCT05242861
Recruiting
Retrospective Study of Brachytherapy
Brachytherapy
NCT05992597 Phase 2
Recruiting
ZR2 Sequential Immunochemotherapy for Newly Treated MCL
Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
NCT06832267
Recruiting
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
Primary Central Nervous System Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology